Drug Combination Details

General Information of the Combination (ID: C07208)
Name Anisodine   NP Info  + Recombinant tissue plasminogen activator   Drug Info 
Structure +
Disease
Retinal vascular occlusions [ICD-11: 9B74]
Investigative [1]
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally
    α. Decreasing Adverse Drug Reaction by This Combination
                 Decreasing Adverse Drug Reaction     Click to Show/Hide
                    Experiment 1 Reporting the Effect of This Combination [1]
                    In-vivo Model Clinical trial
                    Experimental
                    Result(s)		 Intravenous thrombolysis with rt-PA combined with compound anisodine is safe and effective in treating CRAO, which can significantly improve the prognosis of patients.
References
Reference 1 Observation on therapeutic efficacy of rt-PA intravenous thrombolysis combined with compound anisodine injection on central retinal artery occlusion. Exp Ther Med. 2016 Oct;12(4):2617-2621.
 Download Picture         KEGG Link